综合性老年瘤学:当前实践的审查
Hannah Fine1, Amrita Bonthu2, Mikhail Kogan3
1GW Center for Integrative Medicine, GW University, Washington, D.C, USA.
Current oncology reports
|July 23, 2024
概括
综合医学,包括抗炎饮食和肠道健康,可以改善癌症结果和老年人的生活质量. 这种方法支持老年瘤患者进行复杂的治疗.
科学领域:
- 老年瘤学 老年瘤学
- 综合医学是一个整体的医学.
- 基于证据的实践.
背景情况:
- 老年人的癌症发病率正在上升,预测显示到2050年,80岁以上的人群的癌症发病率将大幅增加.
- 健康衰老研究强调了生活方式因素的重要性,如饮食和肠道微生物群健康,在疾病预防和管理.
- 老年瘤患者面临着独特的挑战,需要超越传统治疗的全面支持.
研究的目的:
- 审查老年瘤患者的最佳整合性医学实践.
- 确定基于证据的方法,以提高老年人癌症结果和生活质量.
- 为医疗保健提供者提供有关生活方式干预措施的知识,以适应老年人癌症护理.
主要方法:
- 综合医学在老年瘤学方面的综合性文献综述.
- 分析支持生活方式干预的证据,如抗炎饮食和肠道微生物组调节.
- 结果的推断,以告知癌症老年人的临床实践.
主要成果:
- 综合性方法,包括饮食干预和肠道健康促进,显示出对整体健康和疾病耐药性的显著积极影响.
- 抗炎饮食和健康的肠道微生物组增强了身体与癌症作斗争的天生的能力.
- 量身定制的整合技术可以改善癌症治疗和副作用管理的老年瘤患者的健康结果和生活质量.
结论:
- 综合医学对于解决老年瘤患者复杂需求至关重要.
- 生活方式干预是老年人整体癌症护理的重要组成部分.
- 拥有整合实践知识的医疗保健提供者可以为患有癌症的老年人提供卓越,以患者为中心的护理.
更多相关视频
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Standards of Care II
Nurses bear specific legal responsibilities under several federal statutes, including:
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


